(Q47722948)

5 February 2018

title

Serum levels of CD137 ligand and CD178 are prognostic factors for progression of myelodysplastic syndrome (English)

1 reference

5 February 2018

Gary C Starling

4

0 references

Peter A Kiener

5

object named as

Peter A Kiener

1 reference

5 February 2018

author name string

Helmut R Salih

1

1 reference

5 February 2018

Volkmar Nuessler

2

1 reference

5 February 2018

Claudio Denzlinger

3

1 reference

5 February 2018

Helga M Schmetzer

6

1 reference

5 February 2018

publication date

1 February 2004

1 reference

5 February 2018

published in

Leukemia & Lymphoma

1 reference

5 February 2018

volume

45

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

301-308

1 reference

5 February 2018

Proposals for the classification of the myelodysplastic syndromes

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001602372

The soluble CD40 ligand sCD154 in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001602372

Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001602372

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001602372

Apoptosis and its significance in MDS: controversies revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001602372

CD137-induced apoptosis is independent of CD95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001602372

Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001602372

Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001602372

Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001602372

4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001602372

10.1080/10428190310001602372

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018